Verici Dx plc (AIM:VRCI)
London
· Delayed Price · Currency is GBP · Price in GBX 0.550
-0.025 (-4.35%)
Mar 9, 2026, 2:33 PM GMT
Verici Dx Revenue
Verici Dx had revenue of $1.91M USD in the half year ending June 30, 2025, with 9,968.42% growth. This brings the company's revenue in the last twelve months to $1.91M, down -55.85% year-over-year. In the year 2024, Verici Dx had annual revenue of $3.34M with 229.62% growth.
Revenue (ttm)
$1.91M
Revenue Growth
-55.85%
P/S Ratio
6.23
Revenue / Employee
$127.53K
Employees
15
Market Cap
8.70M GBP
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 3.34M | 2.33M | 229.62% |
| Dec 31, 2023 | 1.01M | - | - |
| Dec 31, 2022 | - | - | - |
| Dec 31, 2021 | - | - | - |
| Dec 31, 2020 | - | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| CelLBxHealth | 2.62M |
| Oxford BioDynamics | 1.10M |
| GENinCode | 2.91M |
| RUA Life Sciences | 4.46M |
Verici Dx News
- 16 days ago - Half Year 2025 Verici DX PLC Earnings Call Transcript - GuruFocus
- 1 year ago - FBB Biomed Signs Agreement with Verici Dx plc to Offer Research-Use-Only “RUO” Tests to Clinicians - Business Wire